Dube Michael P

EDGAR CIK 0002019493

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
VP, Chief Accounting Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($38,248)
-2,012 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/02/2024
10/04/2024
Sell
-2,012 @ $19.01
 ($38,248) 47,012 (-4.10%) Direct